We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ahmed Hawash

Ahmed Hawash MD, PhD

Resident Physician, Department of Dermatology & Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida

As a doctoral student in the electrophysiology laboratory of Dr. Mark Rich, Dr. Hawash studied myotonia congenita, identifying a novel current in the myotonic mouse muscle and implicating its necessary role in the production of involuntary contraction. He further demonstrated that myotonia can be eliminated by targeting this current pharmacologically using ranolazine. His doctoral work culminated in clinical trials studying the use of ranolazine in myotonia patients with promising results in collaboration with the Ohio State University.

As a medical student, Dr. Hawash was awarded with the 2017 Most Outstanding Medical Student Research Award and was subsequently inducted into the medical school’s prestigious Academy of Medicine.

Ahmed Hawash, MD, PhD, is currently a resident physician in the Department of Dermatology & Cutaneous Surgery at the University of Miami Miller School of Medicine. His clinical interests in dermatology include neurodermatology, wound healing, hair disease, dermatologic surgery, cosmetics and lasers.

Disclosures

Dr. Hawash has no relevant disclosures.